Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 3,280,400 | 3,556,300 | 3,376,900 | 3,465,500 | 3,139,400 |
| Cost of Goods | 810,100 | 796,400 | 751,700 | 731,500 | 679,300 |
| Gross Profit | 2,470,300 | 2,759,900 | 2,625,200 | 2,734,001 | 2,460,100 |
| Operating Expenses | 1,606,800 | 1,854,800 | 2,073,500 | 1,844,700 | 1,531,800 |
| Operating Income | 863,600 | 905,500 | 552,400 | 889,801 | 928,600 |
| Interest Expense | 18,500 | 7,500 | 9,300 | 9,800 | 15,800 |
| Other Income | 123,100 | -59,800 | 72,400 | 83,999 | 3,100 |
| Pre-tax Income | 968,200 | 838,200 | 615,500 | 964,000 | 915,900 |
| Income Tax | 213,000 | 181,300 | 215,100 | 216,800 | 201,500 |
| Net Income Continuous | 755,200 | 656,900 | 400,400 | 747,200 | 714,400 |
| Net Income | $755,200 | $656,900 | $400,400 | $747,200 | $714,400 |
| EPS Basic Total Ops | 0.70 | 0.61 | 0.37 | 0.70 | 0.66 |
| EPS Basic Continuous Ops | 0.70 | 0.61 | 0.37 | 0.70 | 0.66 |
| EPS Diluted Total Ops | 0.69 | 0.60 | 0.37 | 0.69 | 0.66 |
| EPS Diluted Continuous Ops | 0.69 | 0.60 | 0.37 | 0.69 | 0.66 |
| EBITDA(a) | $1,026,800 | $1,055,500 | $700,000 | $996,400 | $1,081,900 |